array biopharma inc
(ARRY:Consolidated Issue listed on NASDAQ Global Market)
Kevin Koch Ph.D.
Co-Founder, Array BioPharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Dr. Kevin Koch, Ph.D., is a Co-Founder of Array Biopharma, Inc. and served as its President and Chief Scientific Officer since May 1998 until November 2013. Prior to in Array, Dr. Koch served as an Associate Director of Medicinal Chemistry and Project Leader for the Protease Inhibitor and New Leads project teams from May 1995 to April 1998 for Amgen Inc. From September 1988 until May 1995, Dr. Koch held various positions with Pfizer Central Research, including Senior ...
3200 Walnut StreetPhone: 303-381-6600
Boulder, Colorado 80301
Board Members Memberships*
State University of New York
University of Rochester
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Robert I. Blum||Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern|
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer|
|€601.0K||Compensation as of Fiscal Year 2013.|